المؤلفون: Argiris, A, Bauman, JE, Ohr, J, Gooding, WE, Heron, DE, Duvvuri, U, Kubicek, GJ, Posluszny, DM, Vassilakopoulou, M, Kim, S, Grandis, JR, Johnson, JT, Gibson, MK, Clump, DA, Flaherty, JT, Chiosea, SI, Branstetter, B, Ferris, RL

المصدر: Annals of Oncology. 27(8)

مصطلحات موضوعية: Cancer, Clinical Trials and Supportive Activities, Lung, Infectious Diseases, Dental/Oral and Craniofacial Disease, Clinical Research, 6.2 Cellular and gene therapies, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Good Health and Well Being, Antibodies, Monoclonal, Humanized, Bevacizumab, Carcinoma, Squamous Cell, Cetuximab, Disease-Free Survival, ErbB Receptors, Female, Head and Neck Neoplasms, Humans, Male, Molecular Targeted Therapy, Neoplasm Staging, Pemetrexed, Quality of Life, Squamous Cell Carcinoma of Head and Neck, Vascular Endothelial Growth Factor A, bevacizumab, cetuximab, clinical trial, head and neck cancer, pemetrexed, radiation therapy, Oncology and Carcinogenesis, Oncology & Carcinogenesis

الوصول الحر: https://escholarship.org/uc/item/7958x5d2Test

المؤلفون: Dougall AL, Smith AW, Somers TJ, Posluszny DM, Rubinstein WS, Baum A

المصدر: Psychosomatic Medicine; 2009 Jan, Vol. 71 Issue 1, p98-105, 8p